InsidersTradesSigma
JW중외제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the JW중외제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, JW중외제약 has published 1 public disclosures. Market capitalisation: €177.8bn. The latest transaction was disclosed on 2 July 2026 (Other). Among the most active insiders: JW홀딩스. The full history is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Fundamental score
Ranked 1,413 of 26,211 companies
78.5
score / 100
Value93
Quality64
FCF yld15%
Earn yld16%
EV/EBITDA4.3x
ROE14%
Gross mgn28%
Net mgn11%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
About JW중외제약
JW Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the XKRX.